Developing treatments for impaired cognition in schizophrenia
Related Experiment Video
Updated: May 26, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Michael J Minzenberg1, Cameron S Carter
1Department of Psychiatry and Center for Neuroscience, University of California Davis School of Medicine, Sacramento, CA 95817, USA. michael.minzenberg@ucdmc.ucdavis.edu
Abstract:
Schizophrenia is one of the most debilitating of all common brain disorders, exacting a heavy toll on the afflicted and having a tremendous public health impact. Clinical outcome is more strongly predicted by cognitive deficits than psychotic symptoms, with no established treatment for these deficits. In this review, we discuss the status of treatment development for impaired cognition in schizophrenia. These treatments include a range of pharmacological targets within diverse neurotransmitter systems. New technologies, including transcranial magnetic stimulation and transcranial direct current stimulation, and psychological therapies, such as computer-based cognitive training, may also benefit cognition in schizophrenia. Each of these approaches shows promise and their integration may optimize benefits for patients in the future.
Related Concept Videos
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Psychosis: Goals of Pharmacotherapy
Drug Therapy
Antianxiety Medications
Cognitive Development During Adulthood
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
